Comparative Pharmacology
Head-to-head clinical analysis: PENTIDS 400 versus VEETIDS 500.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PENTIDS 400 versus VEETIDS 500.
PENTIDS '400' vs VEETIDS '500'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin G binds to penicillin-binding proteins (PBPs) located on the bacterial cell wall, inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking, leading to cell lysis.
VEETIDS '500' (cefuroxime axetil) is a second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby blocking transpeptidation and leading to cell lysis. It has activity against both gram-positive and gram-negative bacteria.
400 mg orally every 6 hours.
1 tablet (500 mg) orally twice daily for 7 days.
None Documented
None Documented
0.5-1 hour in patients with normal renal function. Prolonged to 2-5 hours in renal impairment, requiring dose adjustment.
4-6 hours (prolonged in renal impairment; requires dose adjustment if CrCl <30 mL/min)
Primarily renal (tubular secretion and glomerular filtration); 60-90% of dose excreted unchanged in urine within 24 hours. Minor biliary excretion (<10%) and fecal elimination.
Renal: 60-80% unchanged; biliary/fecal: 15-25% as metabolites
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic